Zimmer Biomet Holdings, Inc. ZBH
Price alert —
Sign in to get a one-time email the moment ZBH crosses your price. Free accounts included.
Sign in / create a free accountZimmer Biomet Holdings, Inc. is a healthcare company listed in the US.
ZBH last traded at $91.12, down 2.8% on the day; that's in the middle part of its 52-week range ($79.12–$101.49). Right now it's trading close to its recent average, with no strong stretch in either direction.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
KC1 upper, +0.43 ATR from EMA21 — no notable pattern
- · Chop regime — mean-reversion favored both ways
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · KC1 upper stretch — light pop
- · RSI rolling over (53)
- · Chop regime — mean-reversion favored both ways
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
Our cash-flow model pegs fair value near $85.11 (fair range $69–$128); today's price sits 11% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ✓ Gross margin 70% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.84 (fragile)
- ⚠ Receivables growing faster than revenue
Price implies ~11% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
ZBH is a $17.4 billion company, priced at 24× last year's earnings.